How Gilead Sciences Stock Performed in the First Half of October
On October 12, Gilead Sciences (GILD) closed at $73.59, which was 1.5% higher than its closing price on October 11. This increase in its stock price followed the company’s announcement that it planned to release data from its R&D programs targeting various liver conditions at The Liver Meeting 2018 in San Francisco. Its stock price dropped 1.1% and closed at $72.78 on October 15.